Cutler Group LP Amarin Corp Plcuk Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$1.13 - $3.69 $1,242 - $4,059	-1,100 Reduced 84.62%	200 $0
Q1 2022 Apr 14, 2022	BUY	$2.85 - $3.73 $2,565 - $3,357	900 Added 225.0%	1,300 $2,000
Q3 2021 Oct 26, 2021	SELL	$3.94 - $5.84 $2,364 - $3,504	-600 Reduced 60.0%	400 $4,000
Q2 2021 Jul 19, 2021	SELL	$4.26 - $6.5 $852 - $1,300	-200 Reduced 16.67%	1,000 $18,000
Q1 2021 Apr 26, 2021	SELL	$5.03 - $8.8 $111,163 - $194,480	-22,100 Reduced 94.85%	1,200 $16,000
Q4 2020 Jan 21, 2021	SELL	$4.04 - $5.31 $37,168 - $48,852	-9,200 Reduced 28.31%	23,300 $74,000
Q3 2020 Oct 27, 2020	BUY	$3.64 - $7.76 $69,888 - $148,992	19,200 Added 144.36%	32,500 $132,000
Q2 2020 Jul 22, 2020	SELL	$4.78 - $8.26 $637,174 - $1.1 Million	-133,300 Reduced 90.93%	13,300 $82,000
Q1 2020 May 07, 2020	BUY	$4.0 - $21.53 $291,600 - $1.57 Million	72,900 Added 98.91%	146,600 $1.52 Million
Q4 2019 Feb 06, 2020	SELL	$13.94 - $24.12 $281,588 - $487,224	-20,200 Reduced 21.51%	73,700 $15,000
Q3 2019 Oct 28, 2019	BUY	$13.89 - $23.16 $688,944 - $1.15 Million	49,600 Added 111.96%	93,900 $262,000
Q2 2019 Aug 09, 2019	SELL	$16.27 - $20.51 $330,281 - $416,353	-20,300 Reduced 31.42%	44,300 $26,000
Q1 2019 May 10, 2019	SELL	$12.61 - $22.33 $953,316 - $1.69 Million	-75,600 Reduced 53.92%	64,600 $41,000
Q4 2018 Feb 05, 2019	BUY	$12.41 - $22.98 $429,386 - $795,108	34,600 Added 32.77%	140,200 $389,000
Q3 2018 Nov 07, 2018	BUY	$2.45 - $16.27 $258,720 - $1.72 Million	105,600 New	105,600 $35,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.